TUDCA (Tauroursodeoxycholic Acid) — Frequently Asked Questions
This content is for informational purposes only and does not constitute medical advice. Consult your healthcare provider before starting any supplement. Full disclaimer
Frequently Asked Questions
What is the difference between TUDCA and UDCA?
What is the difference between TUDCA and UDCA?
TUDCA is UDCA conjugated with the amino acid taurine. This conjugation makes TUDCA more water-soluble and potentially more effective at displacing toxic bile acids. UDCA (ursodiol) is the FDA-approved pharmaceutical for primary biliary cholangitis, while TUDCA is available as a supplement. Both are effective, but TUDCA may have superior cytoprotective properties due to its additional ER stress-reducing effects.
Is TUDCA safe to take with oral steroids or prohormones?
Is TUDCA safe to take with oral steroids or prohormones?
TUDCA is widely used in the bodybuilding community during oral steroid cycles to protect the liver, and its mechanism of action (bile flow improvement, ER stress reduction) is relevant to methylated steroid-induced cholestasis. While no RCTs have specifically studied this use, the pharmacological rationale is sound. Typical doses of 500-1000mg daily are used. However, the safest approach is to avoid hepatotoxic substances altogether.
Can TUDCA help with gallbladder issues?
Can TUDCA help with gallbladder issues?
TUDCA and its parent compound UDCA can help dissolve cholesterol gallstones and improve bile composition. UDCA is FDA-approved for this purpose. TUDCA may also help prevent gallstone formation by improving bile flow and altering bile acid composition to be more hydrophilic. If you have gallbladder disease, consult your physician before supplementing.
References
- Pan XL, Zhao L, Li L, Li AH, Ye J, Yang L, Xu KS, Hou XH (2013). Efficacy and safety of tauroursodeoxycholic acid in the treatment of liver cirrhosis: A double-blind randomized controlled trial. Journal of Huazhong University of Science and Technology - Medical Sciences. DOI PubMed
- Ozcan U, Yilmaz E, Ozcan L, Furuhashi M, Vaillancourt E, Smith RO, Görgün CZ, Hotamisligil GS (2006). Chemical chaperones reduce ER stress and restore glucose homeostasis in a mouse model of type 2 diabetes. Science. DOI PubMed
- Rodrigues CM, Fan G, Ma X, Kren BT, Steer CJ (1998). A novel role for ursodeoxycholic acid in inhibiting apoptosis by modulating mitochondrial membrane perturbation. Journal of Clinical Investigation. DOI PubMed
- Kars M, Yang L, Gregor MF, Mohammed BS, Pietka TA, Finck BN, Patterson BW, Horton JD, Mittendorfer B, Hotamisligil GS, Klein S (2010). Tauroursodeoxycholic acid may improve liver and muscle but not adipose tissue insulin sensitivity in obese men and women. Diabetes. DOI PubMed